4
Changes in Ownership
Editas Medicine, Inc. Filed Acc 0001179110-20-001370
Chief Scientific Officer sold 622 shares at $26.95 ($16,763)
- Chief Scientific Officer acquired 11,593 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Albright Charles · Chief Scientific Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-02-06 | Grant or award : show line 1 in the form | +11,593 | 32,146 | D | ||
| 2020-02-07 | Sale : show line 2 in the form | −622 | $26.95 | $16,763 | 31,524 | D |
| Open-market sales · 622 sh · avg $26.95 · $16,763 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-02-06 | Grant or award : show line 3 in the form Stock Option (right to buy) | +69,556 | 69,556 | D |
Loading xslF345X03/edgar.xml…